- Bedoelde u
- cervical intraepithelial neoplasms
Zoekresultaten - 30 results
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
cervical intraepithelial neoplasia of grade 3 or worse (CIN3 +). METHODS: A literature search was conducted in 3 bibliographic databases. Studies were selected if they included women with ASC- US or LSIL who ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.
suivi de la dysplasie cervicale. Lors du dépistage, les auteurs des lignes directrices ou les envoyer à un kit de collecte automatique du VPH. Les tests de dépistage HPP 16 ou HPV 18 sont positifs. Un ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
Wesselmann, Simone; Nothacker, Monika; Follmann, Markus; Langer, Thomas; Jentschke, Matthias Source: Geburtshilfe Frauenheilkd, Volume 79, Issue 2 (2019) Keywords: cervical cancer cervical intraepithelial ...
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
led to the use of sensitive HPV molecular tests for screening. This study examined the impact of the baseline HPV status on the future risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2 ...
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
retaining vaccination uptake at the current level; vaccinating older women; increasing screening participation; methods for triaging HPV-positive women; improving the diagnosis of cervical intraepithelial ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
a clinician sample; and verification of the presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2 +) by colposcopy and biopsy in all enrolled women or in women with positive tests. Participation ...
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
types and women unselected by HPV status. Expert commentary: All evaluated vaccines offered excellent protection against cervical intraepithelial neoplasia of grade 2 or 3 (CIN2 or CIN3) and ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
1.04) for cervical intraepithelial neoplasia grade 2 or worse (CIN2 +) and 1.01 (95% CI, 0.97 to 1.06) for CIN3 + and relative specificity of 1.02 (95% CI, 1.00 to 1.03) for a CIN grade of ≤1. The ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
Alphapapillomavirus Cervical Intraepithelial Neoplasia Cervix Uteri Diagnostic Tests, Routine DNA, Viral Early Detection of Cancer Female Genotyping Techniques Humans Papillomavirus Infections Uterine Cervical ...
Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.
blinded to the clinical data. HPV prevalence was analysed and clinical performance for detection of cervical intraepithelial neoplasia grade 3 or worse (CIN3 +) and CIN2 or worse (CIN2 +) was assessed ...